Total Payments
$4,190
2024 Payments
$1,095
Companies
21
Transactions
205
Medicare Patients
4,052
Medicare Billing
$220,255
Payment Breakdown by Category
Food & Beverage$3,803 (90.8%)
Education$386.92 (9.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,803 | 200 | 90.8% |
| Education | $386.92 | 5 | 9.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $820.35 | 40 | $0 (2024) |
| Janssen Biotech, Inc. | $730.98 | 39 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $478.86 | 24 | $0 (2024) |
| Amgen Inc. | $311.50 | 15 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $299.79 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $283.53 | 14 | $0 (2024) |
| Incyte Corporation | $207.22 | 10 | $0 (2024) |
| GENZYME CORPORATION | $179.56 | 8 | $0 (2024) |
| PFIZER INC. | $144.42 | 8 | $0 (2023) |
| Lilly USA, LLC | $133.06 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,095 | 44 | Janssen Biotech, Inc. ($271.34) |
| 2023 | $1,356 | 60 | E.R. Squibb & Sons, L.L.C. ($273.96) |
| 2022 | $1,216 | 73 | ABBVIE INC. ($311.05) |
| 2021 | $523.15 | 28 | Janssen Biotech, Inc. ($247.15) |
All Payment Transactions
205 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.90 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.59 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $79.99 | General |
| Category: Immunology | ||||||
| 11/19/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: DERMATOLOGY | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.86 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.91 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Dermatology | ||||||
| 10/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.70 | General |
| Category: Immunology | ||||||
| 09/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Dermatology | ||||||
| 09/11/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.74 | General |
| Category: Dermatology | ||||||
| 09/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 09/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: Immunology | ||||||
| 08/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.68 | General |
| Category: Immunology | ||||||
| 08/12/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: ACNE | ||||||
| 08/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $32.93 | General |
| Category: Immunology | ||||||
| 07/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: IMMUNOLOGY | ||||||
| 07/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Dermatology | ||||||
| 07/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.54 | General |
| Category: Immunology | ||||||
| 06/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,120 | 1,677 | $237,397 | $57,556 |
| 2022 | 14 | 1,091 | 1,647 | $244,430 | $60,474 |
| 2021 | 16 | 1,061 | 1,553 | $241,751 | $64,843 |
| 2020 | 14 | 780 | 1,180 | $163,689 | $37,383 |
Total Patients
4,052
Total Services
6,057
Medicare Billing
$220,255
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 419 | 499 | $71,357 | $24,015 | 33.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 163 | 206 | $41,612 | $6,324 | 15.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 102 | 113 | $27,798 | $5,513 | 19.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 93 | 93 | $21,422 | $4,923 | 23.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 68 | 72 | $19,800 | $4,057 | 20.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 56 | $11,872 | $3,892 | 32.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 107 | 502 | $16,566 | $1,925 | 11.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 50 | 54 | $4,752 | $1,739 | 36.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 15 | 17 | $7,463 | $1,596 | 21.4% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 12 | 13 | $4,875 | $1,343 | 27.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 30 | 39 | $5,187 | $1,162 | 22.4% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 12 | 13 | $4,693 | $1,065 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 349 | 432 | $61,776 | $21,504 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 119 | $25,228 | $8,359 | 33.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 86 | 96 | $26,400 | $5,389 | 20.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 153 | 190 | $38,380 | $5,358 | 14.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 83 | 90 | $22,140 | $5,116 | 23.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 97 | 97 | $21,825 | $4,991 | 22.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 29 | 31 | $13,609 | $3,153 | 23.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 101 | 491 | $16,203 | $1,866 | 11.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $4,995 | $1,383 | 27.7% |
| 10060 | Simple or single drainage of skin abscess | Office | 2022 | 11 | 13 | $3,718 | $864.10 | 23.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 26 | 28 | $2,464 | $823.52 | 33.4% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2022 | 16 | 16 | $3,744 | $819.08 | 21.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 13 | 16 | $2,128 | $510.58 | 24.0% |
About Lauren Curry, PA-C
Lauren Curry, PA-C is a Physician Assistant healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2016. The National Provider Identifier (NPI) number assigned to this provider is 1598219560.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lauren Curry, PA-C has received a total of $4,190 in payments from pharmaceutical and medical device companies, with $1,095 received in 2024. These payments were reported across 205 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,803).
As a Medicare-enrolled provider, Curry has provided services to 4,052 Medicare beneficiaries, totaling 6,057 services with total Medicare billing of $220,255. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Lexington, KY
- Active Since 08/08/2016
- Last Updated 03/17/2018
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1598219560
Products in Payments
- TREMFYA (Drug) $730.98
- Sotyktu (Drug) $478.86
- SKYRIZI (Biological) $436.30
- DUPIXENT (Biological) $269.92
- RINVOQ (Biological) $265.39
- OPZELURA (Drug) $207.22
- Otezla (Drug) $157.09
- COSENTYX (Drug) $141.40
- TALTZ (Drug) $133.06
- EUCRISA (Drug) $128.34
- Bimzelx (Biological) $125.00
- COSENTYX (Biological) $123.26
- HUMIRA (Biological) $118.66
- ADBRY (Biological) $107.54
- ILUMYA (Biological) $107.09
- Enbrel (Biological) $76.42
- Zoryve (Drug) $37.61
- Klisyri (Drug) $33.13
- CYLTEZO (Drug) $31.58
- YCANTH (Drug) $20.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Lexington
Ms. Lauren Meade, Pa-C, PA-C
Physician Assistant — Payments: $586,865
Physician Assistant $586,865
Brandice Harrison, Pa-C, PA-C
Physician Assistant — Payments: $581,472
Physician Assistant $581,472
Amber Erwin, Pa-C, PA-C
Physician Assistant — Payments: $11,278
Physician Assistant $11,278
Mr. Edwin Robbins, Pa-C, PA-C
Physician Assistant — Payments: $9,751
Physician Assistant $9,751
Vedrana Knezevic, Pa-C, PA-C
Physician Assistant — Payments: $9,611
Physician Assistant $9,611
Sarah Dougherty, Pa-C, PA-C
Physician Assistant — Payments: $7,472
Physician Assistant $7,472